Intellia Therapeutics News

Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 16:18 ET

Intellia Therapeutics | 8-K: Current report

Apr 15 16:26 ET

Intellia Therapeutics | 8-K: Current report

Mar 22 09:27 ET

Intellia Therapeutics | 8-K: Current report

Feb 23 17:21 ET

Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 22 16:20 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Feb 22 07:46 ET

Intellia Therapeutics | 8-K: Current report

Feb 1 16:09 ET

Intellia Therapeutics | 8-K: Current report

Jan 4 00:00 ET

Intellia Therapeutics | 8-K: Current report

Dec 6, 2023 07:00 ET

Intellia Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Nov 24, 2023 09:30 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Nov 9, 2023 07:45 ET

Intellia Therapeutics | 8-K: Current report

Nov 2, 2023 07:11 ET

Intellia Therapeutics | 8-K: Current report

Oct 18, 2023 07:30 ET

Intellia Therapeutics | 8-K: Current report

Oct 3, 2023 07:19 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress

Aug 3, 2023 07:45 ET

Intellia Therapeutics | 8-K: Current report

Jun 16, 2023 16:13 ET

Intellia Therapeutics | 8-K: Current report

Jun 12, 2023 07:00 ET

Intellia Therapeutics | DEFA14A: Others

Jun 5, 2023 17:16 ET

Intellia Therapeutics | 8-K: Current report

Jun 5, 2023 16:52 ET

Intellia Therapeutics | 8-K: Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

May 4, 2023 07:41 ET